跳至主要内容
临床试验/CTIS2024-511335-10-01
CTIS2024-511335-10-01进行中(未招募)1 期

Effects of closed-loop automatic control of the inspiratory fraction of oxygen (FiO2-C) on outcome of extremely preterm infants – a randomized controlled parallel group multicenter trial for safety and efficacy - FiO2-C

niversitaetsklinikum Tuebingen AöR0 个研究点目标入组 1,082 人开始时间: 2024年8月6日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,082

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • GA at birth 23+0/7 to 27+6/7 weeks

排除标准

  • Decision not to provide full life support / decision for palliative care only before study entry, Severe congenital abnormalities (particularly those affecting respiratory, cardiovascular, or gastrointestinal function or long-term neuro-cognitive development, whereas a patent ductus arteriosus or a PFO/ASDII is not considered a congenital anomaly in preterm infants), Postnatal age >48h, Lack of device enabling closed-loop automatic control of FiO2 before randomization

研究者

发起方
niversitaetsklinikum Tuebingen AöR

相似试验